Skip to main content

Table 3 Evidence of continuous monitoring and assessment for target organ damage

From: Incorporating the patient-centered approach into clinical practice helps improve quality of care in cases of hypertension: a retrospective cohort study

Topics

FM clinic N = 100

SS clinic N = 100

P-value

History taking

History of hypertension, n

96

78

0.001a

Risk factors, n

92

99

0.035a

Symptoms suggestive of TOD, n

85

65

0.001

Physical examination

BP and PR measurement, n

98

100

0.497a

BMI calculation and WC measurement, n

24

2

<  0.001a

TOD and cardiovascular disease, n

85

45

<  0.001

Laboratory investigation

Fasting plasma glucose, n

93

99

0.065*

Serum TC, HDL-C, LDL-C, triglyceride, n

100

100

N/A

Serum electrolytes, Cr, GFR calculation, n

94

99

0.118a

Hemoglobin or hematocrit, n

43

43

1.000

Urinalysis, n

65

59

0.382

Electrocardiography, n

28

33

0.443

CV risk assessment at OPD, n

3

1

0.621a

  1. BMI body mass index, BP blood pressure, Cr creatinine, CV risk cardiovascular risk, GFR glomerular filtration rate, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, PR pulse rate, TC total cholesterol, TOD target organ damage, WC waist circumference, OPD outpatient clinic
  2. a Fisher’s exact test